It has been suggested that anti-leukotriene medications may play a role in the development of EGPA, but this is controversial.11–14 The current understanding is that prolonged survival of eosinophils due to inhibition of CD95-mediated apoptosis plays a role in EGPA pathogenesis. Here, FAS is linked to eosinophilic granulomatosis with polyangiitis.